Zhaoke Ophthalmology Limited held its Annual General Meeting on 15 May 2026, with all seven resolutions secured by poll.

Resolution highlights: • A 10% share-repurchase mandate and a 20% general share-issuance mandate were each approved with 256.37 million votes in favour, representing 100.00% support. • The issuance mandate extension—allowing the board to add repurchased shares to the issuance limit—passed with 87.41% support (224.10 million votes for; 32.27 million against). • Director renewals saw full support for Executive Director Dr. Li Xiaoyi and Independent Non-executive Director Mr. Liew Fui Kiang (100.00% in favour). Non-executive Director Ms. Tiantian Zhang was re-elected with 87.41% backing. • Shareholders unanimously authorised the board to fix directors’ remuneration and re-appointed KPMG as external auditor. • Amendments to the company’s memorandum and articles of association were approved as a special resolution with 87.41% support.

Capital base and voting context: The company had 548.75 million issued shares eligible to vote, with no treasury or repurchased shares outstanding. Computershare Hong Kong Investor Services acted as scrutineer. No shareholders were required to abstain, and no counter-motions were recorded.

Governance note: Of the seven directors, Chair Dr. Li Xiaoyi attended in person, while the remaining directors joined electronically. All mandates and appointments are effective immediately following the AGM vote.